These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 432240)

  • 1. Glucocorticoid induced protection in experimental traumatic shock.
    Sollott SJ; Galvin MJ; Lefer AM
    Proc Soc Exp Biol Med; 1979 Mar; 160(3):317-20. PubMed ID: 432240
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effects of a novel thromboxane analog in lethal traumatic shock.
    Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
    Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the protective effect of conditioning in rats subjected to Noble-Collip drum trauma.
    Galvin MJ; Sollott SJ; Lefer AM
    Circ Shock; 1979; 6(1):23-9. PubMed ID: 455590
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective actions of nafazatrom in traumatic shock.
    Lefer AM; Messenger M
    Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salutary actions of nimodipine in traumatic shock.
    Lefer AM; Carrow BA
    Life Sci; 1981 Sep; 29(13):1347-53. PubMed ID: 7289786
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective action of 6-keto-prostaglandin E1 in traumatic shock.
    Araki H; Lefer AM
    Prostaglandins Med; 1979 Apr; 2(4):277-84. PubMed ID: 575862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial actions of prostacyclin in traumatic shock.
    Lefer AM; Sollott SL; Galvin MJ
    Prostaglandins; 1979 May; 17(5):761-7. PubMed ID: 386429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
    Levitt MA; Lefer AM
    Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of drug therapy without volume restoration in experimental traumatic shock. Part III. Glucocorticoid.
    Lahdensuu M; Alho A; Rokkanen P
    Ann Chir Gynaecol Fenn; 1975; 64(1):70-3. PubMed ID: 239624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
    Karasawa A; Rochester JA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
    Levitt MA; Stahl G; Lefer AM
    Resuscitation; 1988 Jul; 16(3):211-20. PubMed ID: 2845544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of a neutral protease inhibitor in traumatic shock.
    Hock CE; Lefer AM
    Pharmacol Res Commun; 1985 Mar; 17(3):217-26. PubMed ID: 4011646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N; Johnson G; Siegfried MR; Lefer AM
    Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock.
    Terashita Z; Stahl GL; Lefer AM
    J Cardiovasc Pharmacol; 1988; 12(5):505-11. PubMed ID: 2468048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
    Stahl GL; Bitterman H; Lefer AM
    Thromb Res; 1989 Feb; 53(3):327-38. PubMed ID: 2718150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA; Lefer AM
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of shock using pharmacological doses of corticosteroids].
    Di Carlo V; Chiesa R; Staudacher C
    Minerva Chir; 1977 Nov; 32(22):1439-45. PubMed ID: 600433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.